Thomas Heffron, David Welch, Todd Pillen, Massimo Asolati, Gregory Smallwood, Phil Hagedorn, Chang Nam, Alexander Duncan, Mark Guy, Enrique Martinez, James Spivey, Patricia Douglas, Carlos Fasola, Jill De Paolo, John Rodriguez, Rene Romero – 23 May 2006 – Transplanting blood group A, B, or O (ABO)‐incompatible (ABO‐I) liver grafts has resulted in lower patient and graft survival with an increased incidence of vascular and biliary complications and rejection.

Shin Hwang, Sung‐Gyu Lee, Kwang‐Min Park, Ki‐Hun Kim, Chul‐Soo Ahn, Heung‐Bum Oh, Deok‐Bog Moon, Tae‐Yong Ha, Young‐Suk Lim, Dong‐Hwan Jung – 23 May 2006 – The shortage of cadaveric donor organs has led to the use of living donors and marginal cadaveric donors. To date, there have been only 2 reports on the use of hepatitis B surface antigen (HBsAg)‐positive liver grafts. Here we describe the 5‐yr posttransplantation sequence of a hepatitis B virus (HBV)‐positive recipient who received an HBsAg‐positive living donor liver graft.

Yasuhiko Sugawara, Masatoshi Makuuchi – 23 May 2006

Lunan Yan, Bo Li, Yong Zeng, Tianfu Wen, Jichun Zhao, Wentao Wang, Mingqing Xu, Jiayin Yang, Yukui Ma, Zheyu Chen, Hong Wu – 23 May 2006

Salleh Ibrahim, Chao‐Long Chen, Chih‐Che Lin, Chin‐Hsiang Yang, Chih‐Chi Wang, Shih‐Ho Wang, Yeuh‐Wei Liu, Chee‐Chien Yong, Allan Concejero, Bruno Jawan, Yu‐Fan Cheng – 23 May 2006 – Complications in a donor are a distressing but inevitable occurrence, since graft procurement is a major undertaking. Although the technique for procurement has some similarities to hepatic resection, a donor is very unlike a patient with malignancy. The risk factors identified in these patients cannot be extrapolated to donors.

Christopher R. Lynch, Milan E. Folkers, William R. Hutson – 23 May 2006 – With data from the Women's Health Initiative indicating that estrogen plus progesterone are associated with an increased risk of cardiovascular events, many patients and practitioners are looking for alternative therapies to manage menopausal symptoms. One alternative is black cohosh, an herbal product used primarily to treat these symptoms. In recent years there have been several case reports associating this substance with hepatitis and fulminant hepatic failure.

Luca Aldrighetti, Carlo Pulitanò, Marcella Arru, Renato Finazzi, Marco Catena, Laura Soldini, Laura Comotti, Gianfranco Ferla – 18 May 2006 – Hepatic injury secondary to warm ischemia‐reperfusion (I/R) injury and alterations in haemostatic parameters are often unavoidable events after major hepatic resection. The release of inflammatory mediator is believed to play a significant role in the genesis of these events. It has been suggested that preoperative steroid administration may reduce I/R injury and improve several aspects of the surgical stress response.

Ichiro Tsunematsu, Yasuhiro Ogura, Kayoko Inoue, Akio Koizumi, Nobuhiko Tanigawa, Koichi Tanaka – 18 May 2006 – Adult‐to‐adult living donor liver transplantation (ALDLT) has been accepted as an important option for end‐stage liver disease, but information regarding the risk factors remains fragmentary. We aimed to establish a predictive model for 90‐day survival. In the first step, a total of 286 cases who had received primary ALDLT using a right lobe graft between 1998 and 2004 were randomly divided into 2 cohorts at a ratio of 2:1 (191 vs. 95 recipients).

Giorgio Ercolani, Gian Luca Grazi, Matteo Ravaioli, Massimo Del Gaudio, Matteo Cescon, Giovanni Varotti, Giovanni Ramacciato, Gaetano Vetrone, Matteo Zanello, Antonio Daniele Pinna – 18 May 2006 – Impact of hepatitis C virus (HCV) recurrence on long‐term outcome after orthotopic liver transplantation (OLT) is highly variable, and the role of retransplantation is still debated. From 1996 to 2003, 131 OLT with histologically proven HCV recurrence and 6 months of follow‐up were retrospectively reviewed. One and 5‐yr overall survivals were 90.7 and 81.3%, respectively.

Jean F. Botha, Wendy J. Grant, Clarivet Torres, Angie K. Iverson, Debra L. Sudan, Byers W. Shaw, Alan N. Langnas – 18 May 2006 – Infants with short bowel syndrome (SBS) and associated liver failure are often referred for combined liver/intestinal transplantation. We speculated that in some young children, nutritional autonomy would be possible with restoration of normal liver function. Features we believed to predict nutritional autonomy include history of at least 50% enteral tolerance, age less than 2 yr, and no underlying intestinal disease.